FDA Clears QIAGEN's anus C. difficile QS-RGQ MDx Kit, developed in partnership with IMDx; IMDx and QIAGEN Continue to Expand Pipeline for QlAsymphony SP/AS and Rotor-Gene Q Instruments Waltham, MA — In April 2014, the FDA cleared the QIAGEN anus C. difficile QS-RGQ MDx Kit, developed and manufactur

veloped and manufactured by IMDx, for use on the QIAGEN QlAsymphony RGQ MDx System. In addition, IMDx and QIAGEN continue to expand the pipeline for QlAsymphony SP/AS and Rotor- Gene Q Instruments. My best, Alice FDA Clears QIAGEN's artus C. difficile QS-RGQ MDx Kit, developed in partnership with IMDx; IMDx a